Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Publications

SARS-CoV-2 infection and COVID-19 vaccination rates in pregnant women in Scotland

Stock SJ. et al, (2022), Nature Medicine

Inverse and correlative relationships between TRIBBLES genes indicate non-redundant functions during normal and malignant hemopoiesis

Salom� M. et al, (2018), Experimental Hematology, 66, 63 - 78.e13

Targeting BCR-ABL independent TKI resistance in chronic myeloid leukaemia by mTOR and autophagy inhibition

Mitchell R. et al, (2018), Journal of the National Cancer Institute, 110, 467 - 478

Hsa-mir183/EGR1-mediated regulation of E2F1 is required for CML stem/progenitor cell survival

Pellicano F. et al, (2018), Blood, 131, 1532 - 1544

Bone marrow niche trafficking of miR-126 controls the self-renewal of leukemia stem cells in chronic myelogenous leukemia

Zhang B. et al, (2018), Nature Medicine, 24, 450 - 462

Hsa-mir183/EGR1-mediated regulation of E2F1 is required for CML stem/progenitor cell survival

Pellicano F. et al, (2018), Blood, 131, 1532 - 1544

CML cells actively evade host immune surveillance through cytokine-mediated downregulation of MHC-II expression

Tarafdar A. et al, (2017), Blood, 129, 199 - 208

Oncogene addiction in chronic myeloid leukaemia

Jackson L. et al, (2017), eLS, 1 - 9

Validating a network hub in leukaemia stem cells

Hopcroft LE. et al, (2017), Oncoscience, 4, 3 - 4

Epigenetic reprogramming sensitizes CML stem cells to combined EZH2 and tyrosine kinase inhibition

Scott MT. et al, (2016), Cancer Discovery, 6, 1248 - 1257

CXCR2 and CXCL4 regulate survival and self-renewal of hematopoietic stem/progenitor cells

Sinclair A. et al, (2016), Blood, 128, 371 - 383

Dual targeting of p53 and c-MYC selectively eliminates leukaemic stem cells

Abraham SA. et al, (2016), Nature, 534, 341 - 346

CML Cells Actively Evade Host Immune Surveillance Through Cytokine-Mediated Downregulation of MHC-I I Expression

Michie AM. et al, (2016), author - 8856

Identifying Genes and Pathways Deregulated in Chronic Myeloid Leukaemia Stem Cells Through Meta-Analysis of Transcriptomic Data

Jackson L. et al, (2016)

CML Cells Actively Evade Host Immune Surveillance Through Cytokine-Mediated Downregulation of MHC-I I Expression

Michie AM. et al, (2016), 36th World Congress of the International Society of Hematology, 117 - 117

Evolving antithrombotic treatment patterns in patients with newly diagnosed atrial fibrillation: UK findings from the GARFIELD-AF registry

Apenteng P. et al, (2016), BRITISH JOURNAL OF HAEMATOLOGY, 173, 18 - 18

Inhibition of interleukin-1 signaling enhances elimination of tyrosine kinase inhibitor treated CML stem cells

Zhang B. et al, (2016), Blood, 128, 2671 - 2682

Bayesian inference for model selection: an application to aberrant signalling pathways in chronic myeloid leukaemia

Hopcroft LEM. et al, (2015), Systems Genetics: Linking Phenotypes to Genotypes, 161 - 190

JAK2/STAT5 inhibition by nilotinib with ruxolitinib contributes to the elimination of chronic phase CML CD34+ cells in vitro and in vivo

Gallipoli P. et al, (2014), Blood, 124, 1492 - 1501

Models to study chronic myeloid leukemia cancer stem cells

Abraham S. et al, (2014), Cancer Stem Cells

Load More